author-photo

H.-J. Lück

Leibniz University of Hanover

80

Papers

1347

Citations

Citation Trend

Filter By

Papers (80) Sort By

Journal Conference Others

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)
304P Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in patients with locally advanced or metastatic breast cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev

2020
Show All
- Source
- Cite
- Save
Citations (1)
Abstract OT3-02-01: RIBANNA — Real-world evidence of ribociclib plus aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line therapy for postmenopausal women with HR+, HER2– advanced breast cancer (aBC)

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Abstract P2-11-04: Efficacy and safety of darbepoetin alfa or epoetin beta in 2994 high risk early breast cancer patients participating in the German adjuvant intergroup node-positive study (GAIN)

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (13)
Evaluating the impact of relative total dose intensity (RTDI) on patient's short- and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer: A pooled analysis

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
First data from the the Patient's Anastrozole Compliance to Therapy Programme evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract OT3-02-09: Seraphina – Safety efficacy and patient reported outcomes of advanced breast cancer patients: Therapy management with NAB-paclitaxel in daily routine

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)